Literature DB >> 9507201

Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.

R A Zager1, S Conrad, K Lochhead, E A Sweeney, Y Igarashi, K M Burkhart.   

Abstract

Diverse physical and chemical stimuli can activate sphingomyelinases (SMases), resulting in sphingomyelin (SM) hydrolysis with ceramide release. Since ceramide can profoundly impact a host of homeostatic mechanisms, the concept of a "SM (or SMase) signaling pathway" has emerged. We recently documented that ceramide levels fall abruptly during renal ischemia, and then rebound to twice normal values during early reperfusion (30 to 90 min) Therefore, the present study assessed whether these ceramide changes are paralleled, and hence potentially mediated, by comparable changes in SMase activity. Mice were subjected to 45 minutes of renal ischemia +/- 30 minutes, 90 minutes, or 24 hours of reperfusion. Renal cortices (or isolated proximal tubules) were then assayed for SMase activity (acidic, neutral forms). To characterize whether early post-ischemic ceramide increments are a relatively persistent event, ceramide was assayed following a 24-hour reperfusion period. Finally, to assess whether the observed perturbations were unique to post-ischemic injury, SMase and ceramide were quantified in the setting of glycerol-induced myohemoglobinuria and anti-glomerular basement membrane (alpha GBM) antibody-induced acute renal failure (ARF). Ischemia induced abrupt declines (approximately 50%) in both acidic and neutral SMase activities, and these persisted in an unremitting fashion throughout 24 hours of reperfusion. Nevertheless, increased ceramide expression (2x normal) resulted. Myohemoglobinuria also suppressed acidic/neutral SMases, and again, "paradoxical" ceramide increments were observed. Finally, alpha GBM nephritis increased ceramide levels, but in this instance, a correlate was increased SMase activity. These results suggest that: (1) ceramide is an acute renal "stress rectant" increasing in response to diverse renal insults; (2) this response may occur independently of the classic SM pathway, since the ceramide increments can seemingly be dissociated from increased SMase activity; and (3) given the well documented impact of ceramide and the SM(ase) pathway on apoptosis, cell proliferation, differentiation, and tissue inflammation, the present results have potentially broad ranging implications for the induction and evolution of diverse forms of ARF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9507201     DOI: 10.1046/j.1523-1755.1998.00772.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

2.  Renal cholesterol accumulation: a durable response after acute and subacute renal insults.

Authors:  R A Zager; T Andoh; W M Bennett
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 3.  Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR).

Authors:  Rodrigo Yokota; Benjamin Bhunu; Hiroe Toba; Suttira Intapad
Journal:  Kidney360       Date:  2021-01-07

Review 4.  Ceramide and mitochondria in ischemia/reperfusion.

Authors:  Sergei A Novgorodov; Tatyana I Gudz
Journal:  J Cardiovasc Pharmacol       Date:  2009-03       Impact factor: 3.105

5.  Biomechanical regulation of cyclooxygenase-2 in the renal collecting duct.

Authors:  Yu Liu; Daniel Flores; Rolando Carrisoza-Gaytán; Rajeev Rohatgi
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-13

Review 6.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

7.  Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction.

Authors:  María José Hernández-Corbacho; Russell W Jenkins; Christopher J Clarke; Yusuf A Hannun; Lina M Obeid; Ashley J Snider; Leah J Siskind
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

Review 8.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

Review 9.  Lipid mediators in diabetic nephropathy.

Authors:  Swayam Prakash Srivastava; Sen Shi; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2014-09-03

Review 10.  Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.